世界の血液治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hematology Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2765 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、血液治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx治療薬）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・血液治療の市場動向 ・企業の競争状況、市場シェア ・血液治療の種類別市場規模（OTC、Rx治療薬） ・血液治療の用途別市場規模（病院、ドラッグストア、その他） ・血液治療の北米市場規模2016-2027（アメリカ、カナダ） ・血液治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・血液治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血液治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・血液治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Celgene、Pfizer、Roche、Sanof、Bristol-Myers Squibb、AbbVie、Novartis、GSK、Johnson & Johnson、Takeda） ・結論

In this report, we study the drugs for Hematology. Hematology is the science or study of blood, blood-forming organs and blood diseases. In the medical field, hematology includes the treatment of blood disorders and malignancies, including types of hemophilia, leukemia, lymphoma and sickle-cell anemia.

Market Analysis and Insights: Global Hematology Treatment Market
The global Hematology Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hematology Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hematology Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hematology Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hematology Treatment market.

Global Hematology Treatment Scope and Market Size
Hematology Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hematology Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
OTC
Rx Drugs

Segment by Application
Hospital
Drugs Store
Other

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Celgene
Pfizer
Roche
Sanof
Bristol-Myers Squibb
AbbVie
Novartis
GSK
Johnson & Johnson

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematology Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Hematology Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hematology Treatment Market Perspective (2016-2027)
2.2 Hematology Treatment Growth Trends by Regions
2.2.1 Hematology Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hematology Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hematology Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hematology Treatment Industry Dynamic
2.3.1 Hematology Treatment Market Trends
2.3.2 Hematology Treatment Market Drivers
2.3.3 Hematology Treatment Market Challenges
2.3.4 Hematology Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hematology Treatment Players by Revenue
3.1.1 Global Top Hematology Treatment Players by Revenue (2016-2021)
3.1.2 Global Hematology Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hematology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hematology Treatment Revenue
3.4 Global Hematology Treatment Market Concentration Ratio
3.4.1 Global Hematology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematology Treatment Revenue in 2020
3.5 Hematology Treatment Key Players Head office and Area Served
3.6 Key Players Hematology Treatment Product Solution and Service
3.7 Date of Enter into Hematology Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hematology Treatment Breakdown Data by Type
4.1 Global Hematology Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hematology Treatment Forecasted Market Size by Type (2022-2027)

5 Hematology Treatment Breakdown Data by Application
5.1 Global Hematology Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hematology Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hematology Treatment Market Size (2016-2027)
6.2 North America Hematology Treatment Market Size by Type
6.2.1 North America Hematology Treatment Market Size by Type (2016-2021)
6.2.2 North America Hematology Treatment Market Size by Type (2022-2027)
6.2.3 North America Hematology Treatment Market Size by Type (2016-2027)
6.3 North America Hematology Treatment Market Size by Application
6.3.1 North America Hematology Treatment Market Size by Application (2016-2021)
6.3.2 North America Hematology Treatment Market Size by Application (2022-2027)
6.3.3 North America Hematology Treatment Market Size by Application (2016-2027)
6.4 North America Hematology Treatment Market Size by Country
6.4.1 North America Hematology Treatment Market Size by Country (2016-2021)
6.4.2 North America Hematology Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hematology Treatment Market Size (2016-2027)
7.2 Europe Hematology Treatment Market Size by Type
7.2.1 Europe Hematology Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hematology Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hematology Treatment Market Size by Type (2016-2027)
7.3 Europe Hematology Treatment Market Size by Application
7.3.1 Europe Hematology Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hematology Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hematology Treatment Market Size by Application (2016-2027)
7.4 Europe Hematology Treatment Market Size by Country
7.4.1 Europe Hematology Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hematology Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hematology Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hematology Treatment Market Size by Type
8.2.1 Asia-Pacific Hematology Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hematology Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hematology Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hematology Treatment Market Size by Application
8.3.1 Asia-Pacific Hematology Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hematology Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hematology Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hematology Treatment Market Size by Region
8.4.1 Asia-Pacific Hematology Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hematology Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hematology Treatment Market Size (2016-2027)
9.2 Latin America Hematology Treatment Market Size by Type
9.2.1 Latin America Hematology Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hematology Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hematology Treatment Market Size by Type (2016-2027)
9.3 Latin America Hematology Treatment Market Size by Application
9.3.1 Latin America Hematology Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hematology Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hematology Treatment Market Size by Application (2016-2027)
9.4 Latin America Hematology Treatment Market Size by Country
9.4.1 Latin America Hematology Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hematology Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hematology Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hematology Treatment Market Size by Type
10.2.1 Middle East & Africa Hematology Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hematology Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hematology Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hematology Treatment Market Size by Application
10.3.1 Middle East & Africa Hematology Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hematology Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hematology Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hematology Treatment Market Size by Country
10.4.1 Middle East & Africa Hematology Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hematology Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Celgene
11.1.1 Celgene Company Details
11.1.2 Celgene Business Overview
11.1.3 Celgene Hematology Treatment Introduction
11.1.4 Celgene Revenue in Hematology Treatment Business (2016-2021)
11.1.5 Celgene Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Hematology Treatment Introduction
11.2.4 Pfizer Revenue in Hematology Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Hematology Treatment Introduction
11.3.4 Roche Revenue in Hematology Treatment Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Sanof
11.4.1 Sanof Company Details
11.4.2 Sanof Business Overview
11.4.3 Sanof Hematology Treatment Introduction
11.4.4 Sanof Revenue in Hematology Treatment Business (2016-2021)
11.4.5 Sanof Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Hematology Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in Hematology Treatment Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Hematology Treatment Introduction
11.6.4 AbbVie Revenue in Hematology Treatment Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Hematology Treatment Introduction
11.7.4 Novartis Revenue in Hematology Treatment Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 GSK
11.8.1 GSK Company Details
11.8.2 GSK Business Overview
11.8.3 GSK Hematology Treatment Introduction
11.8.4 GSK Revenue in Hematology Treatment Business (2016-2021)
11.8.5 GSK Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Hematology Treatment Introduction
11.9.4 Johnson & Johnson Revenue in Hematology Treatment Business (2016-2021)
11.9.5 Johnson & Johnson Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Hematology Treatment Introduction
11.10.4 Takeda Revenue in Hematology Treatment Business (2016-2021)
11.10.5 Takeda Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hematology Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of OTC
Table 3. Key Players of Rx Drugs
Table 4. Global Hematology Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hematology Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hematology Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hematology Treatment Market Share by Regions (2016-2021)
Table 8. Global Hematology Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hematology Treatment Market Share by Regions (2022-2027)
Table 10. Hematology Treatment Market Trends
Table 11. Hematology Treatment Market Drivers
Table 12. Hematology Treatment Market Challenges
Table 13. Hematology Treatment Market Restraints
Table 14. Global Hematology Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hematology Treatment Market Share by Players (2016-2021)
Table 16. Global Top Hematology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hematology Treatment as of 2020)
Table 17. Ranking of Global Top Hematology Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hematology Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hematology Treatment Product Solution and Service
Table 21. Date of Enter into Hematology Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hematology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hematology Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Hematology Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hematology Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hematology Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hematology Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Hematology Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hematology Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hematology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hematology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hematology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hematology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hematology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hematology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hematology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hematology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hematology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hematology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hematology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hematology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hematology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hematology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hematology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hematology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hematology Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hematology Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hematology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hematology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hematology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hematology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hematology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hematology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hematology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hematology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hematology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hematology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hematology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hematology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Celgene Company Details
Table 62. Celgene Business Overview
Table 63. Celgene Hematology Treatment Product
Table 64. Celgene Revenue in Hematology Treatment Business (2016-2021) & (US$ Million)
Table 65. Celgene Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Hematology Treatment Product
Table 69. Pfizer Revenue in Hematology Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Hematology Treatment Product
Table 74. Roche Revenue in Hematology Treatment Business (2016-2021) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Sanof Company Details
Table 77. Sanof Business Overview
Table 78. Sanof Hematology Treatment Product
Table 79. Sanof Revenue in Hematology Treatment Business (2016-2021) & (US$ Million)
Table 80. Sanof Recent Development
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Hematology Treatment Product
Table 84. Bristol-Myers Squibb Revenue in Hematology Treatment Business (2016-2021) & (US$ Million)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. AbbVie Company Details
Table 87. AbbVie Business Overview
Table 88. AbbVie Hematology Treatment Product
Table 89. AbbVie Revenue in Hematology Treatment Business (2016-2021) & (US$ Million)
Table 90. AbbVie Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Hematology Treatment Product
Table 94. Novartis Revenue in Hematology Treatment Business (2016-2021) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. GSK Company Details
Table 97. GSK Business Overview
Table 98. GSK Revenue in Hematology Treatment Business (2016-2021) & (US$ Million)
Table 99. GSK Recent Development
Table 100. Johnson & Johnson Company Details
Table 101. Johnson & Johnson Business Overview
Table 102. Johnson & Johnson Hematology Treatment Product
Table 103. Johnson & Johnson Revenue in Hematology Treatment Business (2016-2021) & (US$ Million)
Table 104. Johnson & Johnson Recent Development
Table 105. Takeda Company Details
Table 106. Takeda Business Overview
Table 107. Takeda Hematology Treatment Product
Table 108. Takeda Revenue in Hematology Treatment Business (2016-2021) & (US$ Million)
Table 109. Takeda Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hematology Treatment Market Share by Type: 2020 VS 2027
Figure 2. OTC Features
Figure 3. Rx Drugs Features
Figure 4. Global Hematology Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drugs Store Case Studies
Figure 7. Other Case Studies
Figure 8. Hematology Treatment Report Years Considered
Figure 9. Global Hematology Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Hematology Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hematology Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Hematology Treatment Market Share by Regions (2022-2027)
Figure 13. Global Hematology Treatment Market Share by Players in 2020
Figure 14. Global Top Hematology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hematology Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Hematology Treatment Revenue in 2020
Figure 16. Global Hematology Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Hematology Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Hematology Treatment Market Share by Type (2016-2027)
Figure 20. North America Hematology Treatment Market Share by Application (2016-2027)
Figure 21. North America Hematology Treatment Market Share by Country (2016-2027)
Figure 22. United States Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hematology Treatment Market Share by Type (2016-2027)
Figure 26. Europe Hematology Treatment Market Share by Application (2016-2027)
Figure 27. Europe Hematology Treatment Market Share by Country (2016-2027)
Figure 28. Germany Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hematology Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Hematology Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Hematology Treatment Market Share by Region (2016-2027)
Figure 38. China Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hematology Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Hematology Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Hematology Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hematology Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Hematology Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Hematology Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Hematology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Celgene Revenue Growth Rate in Hematology Treatment Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Hematology Treatment Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Hematology Treatment Business (2016-2021)
Figure 60. Sanof Revenue Growth Rate in Hematology Treatment Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Hematology Treatment Business (2016-2021)
Figure 62. AbbVie Revenue Growth Rate in Hematology Treatment Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Hematology Treatment Business (2016-2021)
Figure 64. GSK Revenue Growth Rate in Hematology Treatment Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Hematology Treatment Business (2016-2021)
Figure 66. Takeda Revenue Growth Rate in Hematology Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---